相关数据集
Cross-sectional risk models using quantitative fecal hemoglobin in colorectal cancer screening: a systematic review
Fecal Immunochemical Testing (FIT) is a central tool in colorectal cancer (CRC) screening. To improve the selection of individuals for colonoscopy, risk models combining FIT with additional CRC risk f
Figshare2023-11-14 更新140
Implementation of colorectal cancer screening with Faecal Occult Blood Test (FOBT) in the Netherlands
Study hypothesis: Implementation of colorectal cancer screening with Faecal Occult Blood Test (FOBT) in the Netherlands is feasible. Please note that the follow-up study to this randomised controlled
NIAID Data Ecosystem60
Expected detection rate and associated NNS to detect 1 case of any advanced neoplasm and cancer at screening colonoscopy at age 55 after annual FIT testing from age 50 to age 54, compared to no preceding FIT testing and to strategies with longer intervals between FITs.
Expected detection rate and associated NNS to detect 1 case of any advanced neoplasm and cancer at screening colonoscopy at age 55 after annual FIT testing from age 50 to age 54, compared to no preced
NIAID Data Ecosystem80
